-
Multi-Purpose Drug Boosts Adherence After Heart Attack
3 September 2014. Researchers at Mount Sinai Hospital in New York and National Centre for Cardiovascular Research in Madrid, Spain found a pill combining three cardiovascular drugs usually prescribed separately helps heart attack patients stick to their medications better than the three drugs taken separately. The team led by Valentin Fuster, accredited to both institutions,…
-
Breakthrough Status Given Parkinson’s Psychosis Drug
2 September 2014. Acadia Pharmaceuticals says the U.S. Food and Drug Administration designated its drug candidate pimavanserin as a breakthrough therapy for the treatment of psychosis associated with Parkinson’s disease. Acadia is a biopharmaceutical company in San Diego specializing in neurological and central nervous system disorders. Pimavanserin is Acadia’s lead therapy candidate, to be offered…
-
U.S. Diet Quality Improves, But Still Not Healthy
2 September 2014. A study by researchers at Harvard University shows some improvement in the health benefits of food eaten by Americans over the last decade, but the overall quality of the American diet remains poor. The study led by nutrition and epidemiology professor Walter Willett appears online in the journal JAMA Internal Medicine (paid…
-
Labor Day 2014
1 September 2014. Today is Labor Day in the U.S. and Labour Day in Canada, thus Science & Enterprise will be taking a break. Regular posting resumes tomorrow. Way before rap, there was talking blues. Here’s a recording of the late Pete Seeger with a talking blues song for Labor Day, Talking Union. * * …
-
Humanoid Robots Help Children with Autism Learn Interaction
29 August 2014. Engineers and computer scientists at University of Southern California in Los Angeles show how commercial humanoid robots can help children with autism spectrum disorder learn basic social behavior. The team from the lab of Maja Mataric´, director of USC’s Robotics and Autonomous Systems Center, presented its findings earlier this week at the IEEE…
-
Ebola Vaccine Safety Trials Scheduled in U.S., U.K., Africa
28 August 2014. Early-stage clinical trials testing the safety of new vaccines to protect against the Ebola virus are scheduled to begin as early as next week at sites in the U.S., United Kingdom, Mali, and The Gambia in West Africa. The vaccines are being developed by National Institute of Allergy and Infectious Diseases (NIAID),…
-
Biotech, Universities to Test Hydrogel for Vocal Fold Scars
28 August 2014. BioTime Inc., a biotechnology company in Alameida, California, is partnering with researchers at University of Wisconsin and Université catholique de Louvain in Belgium to test its hydrogels for treating vocal cord scarring, a voice problem that results from injury or disease. Financial terms of the collaboration were not disclosed. Vocal folds are…
-
Smartphone App Screens Infants for Jaundice
27 August 2014. Computer scientists and medical researchers at University of Washington in Seattle are developing a system that lets physicians or parents with a smartphone screen newborn infants for jaundice. The system is described in a paper to be presented on 16 September at the ACM International Joint Conference on Pervasive and Ubiquitous Computing (UbiComp…
-
Ionic Liquids Shown to Combat Bacterial Biofilms
27 August 2014. Researchers at Los Alamos National Lab in New Mexico developed a way to harness ionic liquids — salts in a liquid state — that in lab tests disrupt biofilms, antibiotic-resistant bacterial colonies, and boost treatments for skin infections. The team led by Los Alamos Lab’s David Fox and Samir Mitragotri at University…
-
Implant Developed to Measure Pressure Causing Glaucoma
26 August 2014. Biomedical engineers at Stanford University in California and Bar-Ilan University in Israel designed an implanted device for people with glaucoma to take frequent and accurate measures of high pressure inside their eyes, a factor closely associated with glaucoma. The team led by Stanford bioengineering professor Stephen Quake and Bar-Ilan ophthalmologist Yossi Mandel…